Arthrosi Therapeutics

San Diego, CA · Founded 2018 · Privately Held (backing)

Developer of biotechnology drugs designed to reduce flare and tophi in gout patients. Arthrosi Therapeutics is based in San Diego, CA and was founded in 2018. It was valued at $1.5 billion at a merger or acquisition in Dec 2025, the last priced event on record. It has raised $299 million across 7 recorded rounds; the latest was a $60.9 million later-stage round in Jun 2025.

PMV mark · valuation
$1.5B
Oct 2026
Priced at
a merger or acquisition
Dec 2025
Total raised
$298.8M
Last round
Later Stage VC
Jun 2025

Who backs Arthrosi Therapeutics?

16 investors
InvestorType
Heda VenturesOther
Viva BioInnovatorOther
JMCR Family OfficeFamily office
Highlight Capital PartnersHedge fund
LTS Capital AdvisorsFamily office
CR Biotech—
Changrong Capital—
FengHe Fund Management—
Guangrun Health Industry—
H7 BioCapital—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Arthrosi Therapeutics investors

16 investors are on record for Arthrosi Therapeutics, including Heda Ventures, Viva BioInnovator, JMCR Family Office and Highlight Capital Partners. The later-stage round in Jun 2025 drew 13 investors.

Free account
More of Arthrosi Therapeutics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Arthrosi Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Arthrosi Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View